Home>>Signaling Pathways>> Neuroscience>> Histamine Receptor>>Dimethindene maleate

Dimethindene maleate

Catalog No.GC66445

Dimethindene maleate is a selective histamine H1 antagonist with antihistamine effects. Dimethindene maleate can be used for the research of hypersensitivity reactions.

Products are for research use only. Not for human use. We do not sell to patients.

Dimethindene maleate Chemical Structure

Cas No.: 3614-69-5

Size Price Stock Qty
5mg
$108.00
In stock
10mg
$171.00
In stock
25mg
$360.00
In stock
50mg
$576.00
In stock
100mg
$882.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Dimethindene maleate is a selective histamine H1 antagonist with antihistamine effects. Dimethindene maleate can be used for the research of hypersensitivity reactions[1][2][3].

Dimethindene maleate (1-1000 μM) suppresses the cromakalim-induced/glibenclamide-sensitive K?? currents in a concentration-dependent and reversible manner with an IC50 value of 29.5 μM[2].
Dimethindene maleate (1-1000 μM) inhibits Y-26763-induced glibenclamide-sensitive K?? currents with an IC50 value of 49 μM[2].

Dimethindene maleate (0.25 mg; i.p. once) affects wound healing in mice[1].

Animal Model: C57BL/6 mice with wound healing[1]
Dosage: 0.25 mg
Administration: Intraperitoneal injection; 0.25 mg once
Result: Significantly delayed skin wound and only showed wound closure impairment in the initial phase wound healing.

Reviews

Review for Dimethindene maleate

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Dimethindene maleate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.